\n<\/p>\n
The Switzerland stock market ended on a bright note on Tuesday, extending gains from previous session, amid optimism about additional U.S. stimulus, greater momentum in vaccination rollout and on easing concerns about retail trading frenzy.<\/p>\n
For the second straight day, several markets<\/span> across Europe closed notably higher. The mood in Asian and the U.S. markets also was fairly bullish.<\/p>\n The benchmark SMI, which rose to 10,857.05 around mid morning, ended the session with a gain of 63.35 points or 0.59% at 10,803.57.<\/p>\n Swatch Group, Swiss Life Holding and Credit Suisse gained 2.4 to 2.9%. Alcon, LafargeHolcim, Richemont and ABB ended higher by 2 to 2.2%, while Swiss Re and UBS Group gained 1.9% and 1.8%, respectively.<\/p>\n Partners Group, Sika, Zurich Insurance Group and SGS also ended notably higher, while Givaudan ended lower by about 1.6%.<\/p>\n Among the stocks in the Mid Price Index, Julius Baer gained more than 4.5%. According to reports, Julius Baer is considering large scale M&A deals in the near future. <\/p>\n The bank’s CEO Philipp Rickenbacher said in an earnings call on Monday that a deal close to CHF 100bn ($118bn) in assets for the bank “could be a reality, again, in the future. We will see.”<\/p>\n Logitech and OC Oerlikon Corp gained 3.8% and 3.7%, respectively, while AMS, Sonova, Straumann Holding, Flughafen Zurich and Georg Fisher moved up 2 to 3%.<\/p>\n Among the other major markets in Europe, Germany and France ended sharply higher, with their benchmark indices DAX and CAC 40 climbing 1.56% and 1.86%, respectively. The U.K.’s FTSE 100 advanced 0.78% and the pan European Stoxx 600 ended 1.29% up. <\/p>\n<\/p>\n Market Analysis<\/p>\n<\/div>\n